Nelson Advisors

Nelson Advisors is one of Europe's leading mergers and acquisitions (M&A) advisory firms, exclusively dedicated to the dynamic and rapidly evolving healthcare technology (HealthTech) sector. With a deep understanding of market dynamics and technological advancements, they empower innovative HealthTech companies and strategic investors to navigate complex transactions and achieve their growth ambitions. The firm provides a comprehensive suite of M&A services, including buy-side and sell-side advisory, corporate divestitures, roll-up strategies, and tech asset sales. These are complemented by strategic advisory services such as Go-To-Market strategies and international expansion. Nelson Advisors employs a unique "Build, Buy, Partner, Sell" framework, guiding clients in maximising shareholder value and investment returns, which reflects a holistic approach to corporate strategy beyond mere transaction execution. 'Co-founded by Lloyd Price and Paul Hemings, Nelson Advisors leverages over two decades of combined entrepreneurial and global M&A experience. Both partners possess a proven track record of building, scaling, and successfully exiting HealthTech businesses, providing them with invaluable firsthand insight into the sector's challenges and opportunities.' This operational experience, coupled with extensive corporate finance expertise, positions them as trusted advisors. By concentrating solely on Healthcare Technology, Nelson Advisors offers deep industry-specific knowledge and a network that generalist M&A firms cannot match. Their tailored solutions and hands-on approach, evident in average client engagements lasting 6 to 9 months, underscore their commitment to sustainable success for entrepreneurs, boards, and investors in a rapidly evolving market.